Acquisition expands Quantum-Si’s capabilities in semiconductor chip assembly and packaging GUILFORD, Conn. -- Quantum-Si Incorporated (NASDAQ: QSI) ("Quantum-Si," "QSI" or the "Company"), a life sciences tools company commercializing a unique single molecule protein sequencing platform, today announced that it acquired Majelac Technologies LLC, a privately-owned company providing semiconductor packaging and integrated circuit assembly services. The acquisition [...]

Finding high end user interest in the unique N-Rich functionality embedded in the Contichrom CUBE instrument, YMC launches an in-house service to amplify minute impurity peaks for end users. Devens, MA USA – YMC America adds to its lab services a program to magnify impurities in small and large biologics. Increasing otherwise minute peaks enables [...]

CHARLESTON, S.C. -- GlycoPath Inc., developer of advanced bioanalytical assays based on its proprietary GlycoTyper™ immunoaffinity technology, announced their launch of the first research-based kit for N-Glycan Imaging Mass Spectrometry, giving researchers the practical expertise and means to determine the tissue spatial distribution of N-glycans to enhance their biomedical investigations. Each kit not only comes with [...]

MANASSAS, Virginia – Ceres Nanosciences (Ceres), a privately held company that makes innovative products to improve life science research and diagnostic testing, is announcing the establishment of nine new wastewater-based epidemiology centers of excellence, as part of the April 2021 $8.2 million award from the National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADxSM) initiative. [...]

Dublin, Ireland: ERS Genomics Limited (‘ERS’) is pleased to report that China Patent No. 2017105856905 has been granted. This new patent covers methods and compositions for use of CRISPR/Cas9 in eukaryotes. ERS, co-founded by Dr. Emmanuelle Charpentier, 2020 Nobel Prize winner for gene-editing, provides access to the foundational CRISPR/Cas9 intellectual property. With this patent in China, the fundamental [...]

NEW YORK -- Accenture (NYSE: ACN) has made a strategic investment, through Accenture Ventures, in Geneyx Genomex Ltd. (Geneyx), an Israel-based developer of genomic analysis and interpretation software. Geneyx helps improve patient outcomes associated with hereditary and rare diseases by providing disease-specific, clinically relevant insights around risk prediction, diagnosis, prognosis, and treatment for clinical and pharmaceutical organizations. Today, [...]

Rigaku Corporation (Tokyo, Japan) are proud to unveil their new MiniFlex XpC X-ray diffractometer (XRD) at the prestigious JASIS analytical instruments tradeshow in Chiba, Japan. The MiniFlex XpC has been optimized for high-throughput quality control applications in industrial environments, bringing lab quality performance to the manufacturing floor. Primarily designed for the cement industry, it is also suited for applications [...]

IPSWICH, MA – New England Biolabs (NEB®) announced today that they have released a kit for the generation of in vitro transcribed synthetic mRNA capped using the TriLink Biotechnologies, part of Maravai LifeSciences (NASDAQ: MRVI), CleanCap Reagent AG. NEB’s portfolio of HiScribe in vitro transcription (IVT) kits is designed to simplify workflows while producing high yields of RNA. The new HiScribe T7 mRNA Kit with CleanCap [...]

REDWOOD CITY, Calif. -- Seer, Inc., (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced it has appointed Rachel Haurwitz, Ph.D. to serve on its Board of Directors, effective November 8, 2021. Dr. Haurwitz is currently CEO of Caribou Biosciences, Inc. a clinical-stage biopharmaceutical company developing genome-edited off-the-shelf immune [...]

Joins “Business Ambition for 1.5˚C” campaign of the Science-Based Targets initiative Commitment to achieve by 2030 at least 40% reduction in Scope 1 and 2 emissions, and at least 10% reduction in Scope 3 emissions, on way to reach net-zero carbon emissions by 2050 VENLO, Netherlands & HILDEN, Germany -- QIAGEN N.V. (NYSE: QGEN; Frankfurt [...]